Acute infarction ramipril efficacy study results continued 6 12 18 24 30 months after randomization 0 35 30 25 20 0 no. Adverse reactions except laboratory abnormalities considered possiblyprobably related to study drug that occurred in more than 1% of patients and more frequently on altace are shown below. The decision to prescribe and take a product should always be made on the basis of the most recent version of the product information and product package insert in the country of prescription. United states court of appeals for the federal circuit. Effects of ramipril on coronary events in highrisk persons. Aire study randomised, placebocontrolled trial of ramipril in 2006 postami patients with clinical heart failure. Followup visits were at 1 month and then every 6 months. Ramipril, sold under the brand name altace among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. The acute infarction ramipril efficacy aire study investigators. Estimating the cost effectiveness of ramipril used for specific clinical indications article in american journal of cardiovascular drugs 76.
The trial was a twobytwo factorial study evaluating both ramipril and vitamin. Data from the acute infarction ramipril efficacy aire study were analysed retrospectively. Effect of ramipril on mortality and morbidity of survivors of acute. Outcomes were assessed independently by members of an endpoints committee blinded to treatment allocation. The hope study was designed as a large, simple, doubleblind, randomized trial with a 232 factorial design, evaluating the effects of an acei, ramipril, and an antioxidant, vitamin e, their combination, or equivalent placebos on cv events in a highrisk group during a 5. The hope study heart outcomes prevention evaluation. We wished to examine the mortality and morbidity outcomes and modes of.
Alistair hall and colleagues1 report the longterm survival benefits of ramipril in heart failure after acute myocardial infarction, but the data presented do not fully support their conclusions. The combined primary endpoint was the development of. Survival after acute myocardial infarction has been enhanced by treatment with. The data which is used in this research was gathered under the aire study.
Aire describes a study in which about 2000 patients who had shown clinical evidence of heart failure, many of whom suffered from hypertension, were treated with ramipril or a placebo. The acute infarction ramipril efficacy aire 6 study differed from the save and trace studies. If you are not sure, talk to your doctor before taking tablets flat tablets. Assessment of single versus twice daily dosing of ramipril. Costeffectiveness of the treatment of heart failure with. The aire study tested the hypothesis that patients with acute myocardial infarction. Three years after the aire study closed, mortality status of all patients was assessed through government records. Cost effectiveness in the treatment of heart failure with. The acute infarction ramipril efficacy aire study was a multicentre, multinational, doubleblind, placebo controlled study in 1986 patients with acute mi and clinical evidence of heart failure patients with severe heart failure resistant to conventional therapy excluded randomized within 310 days mean 5. However, there remains a substantial subgroup of patients who manifest clinical evidence of heart failure despite the first two of these treatments, an. Methods the aire study randomized 2006 patients with clinical or radiological evidence of heart failure within 29 days of a myocardtal infarction to receive.
Effect of ramipril on mortality and morbidity of survivors of. Methods and resultsa thirdparty perspective was chosen medicare for the united states and ministry of health for canada. Cost implications of the use of ramipril in highrisk. Effects of an angiotensinconvertingenzyme inhibitor. This was a multinational mainly european 161center, 2006patient, doubleblind, randomized, parallelgroup study comparing altace to placebo in stable patients, 29 days after an acute myocardial infarction, who had shown clinical signs of congestive heart failure at any time after the myocardial infarction.
The acute infarction ramipril efficacy study aire study investigated more than 2000 patients over the age of 18 with clinical symptoms of heart failure after acute myocardial infarction. Objective to assess the cost effectiveness of ramipril treatment in patients at low, medium, and high risk of cardiovascular death. The heart outcomes prevention evaluation hope study was designed to test the hypotheses that two preventive intervention strategies, namely angiotensinconverting enzyme ace inhibition or vitamin e, would improve morbidity and mortality in patients at high risk. Acute infarction ramipril efficacy study american college of.
Adverse reactions except laboratory abnormalities considered possiblyprobably related to study drug that occurred in more than 1% of patients and more frequently on ramipril are shown below. Also used to prevent cardiovascular disease in those at high risk. The aire study was the first trial to show survival benefits of the acei ramipril in these patients. A clinical trial of the angiotensinconvertingenzyme. Questions and answers on the referral for tritace tablet. There were 992 patients in the placebo group and 1,014 in the ramipril group. Description and results of aire, 1993 clinical trial comparing ramipril versus placebo in acute myocardial infarction. These estimates were based on the acute infarction ramipril efficacy aire study and on complementary swedish healthcare resour. Methods the aire study randomized 2006 patients with clinical or radiological evidence of heart failure within 29 days of a myocardtal infarction to receive ramipril 5 mg b. Summarywe estimated the cost effectiveness of adding the ace inhibitor ramipril to conventional treatment in patients with heart failure after acute myocardial infarction. In the aire study, a 27 percent reduction in mortality was observed among patients treated with. The lancet articles effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure the acute infarction ramipril efficacy aire study investigators 1 2 1 members of the aire study group and participants in the study are listed at the end of the article 2 correspondence to.
The agencys committee for medicinal products for human use chmp has concluded that there is a need to. Study design the study had a twobytwo factorial design with randomisation of participants to 10 mg ramipril or placebo taken once daily in the evening and 400 iu vitamin e or placebo daily. Aire acute infarction ramipril efficacy study 35 placebo 30 y ramipril t i 25 l 2. Altace tablets ramipril are supplied as tablets for oral administration containing 1. Ramipril reduced mortality and cardiovascular morbidity in. Effect of ramipril on mortality and morbidity of survivors. Prof s g ball, academic unit of cardiovascular studies. It is a reasonable initial treatment for high blood pressure. A longterm follow up study by leeds of the trials uk patients showed that. All of these trials showed reduced progression to congestive heart failure. The followup time was between 6 and 46 months for this study. Pdf blocker treatment and other prognostic variables. We calculated the costs of the management strategies of ramipril and placebo. In particular, 289 29% of the patients receiving ramipril had hypertension.
Design population based cost effectiveness analysis from the perspective of the health care provider in the uk. Ramipril reduced mortality and cardiovascular morbidity in high risk adults the heart outcomes prevention evaluation study investigators. Effect of ramipril on morbidity and mode of death among. Followup study of patients randomly allocated ramipril or. The main objective of the aire study was to compare the effects of the addition of ramipril to conventional therapy with conventional therapy alone. Effect of ramipril on morbidity and mode of death among survivors of.
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. In the acute infarction ramipril efficacy aire study, the effect of angiotensinconvertingenzyme ace inhibition on the survival of patients with clinical heart failure after acute myocardial infarction ami, was assessed. In this study, we report the cost implications, in both the united states and canada, of the use of ramipril after the hope study. Mi presentation reduction, 16 in fatal mi and 26 in other mi types. Jraas the hope study heart outcomes prevention evaluation. This study was designed to examine the longterm mean of five years effects of altace 10 mg orally once a day on the combined endpoint of.
Link between effectiveness and cost data costing on hospitalisation was retrospectively conducted on a subsample of the patient sample used in the aire study 4 out of 10 participating swedish hospitals. Blood tests showing a decrease in the number of red you. Ramipril significantly reduces cardiovascular events including mi, stroke and death in high riskpatients in the absence of left ventricular dysfunction original date of. Effectiveness was modelled using data from the hope heart outcome prevention evaluation trial. Effects of an angiotensinconvertingenzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in highrisk patients. The evidence for the final outcomes was based on a single study the acute infarction ramipril efficacy study the aire study. The heart outcomes prevention evaluation study investigators.
Estimating the cost effectiveness of ramipril used for. In the acute infarction ramipril efficacy aire study, the effect of angiotensinconvertingenzyme ace inhibition on the survival of patients with clinical heart failure. The inactive ingredients present are calcium sulphate. The largescale acute infarction ramipril efficacy aire study demonstrated that ramipril 5 or 10 mgday significantly decreased the risk of allcause mortality by 27% in patients with clinical evidence of heart failure after acute myocardial infarction, even if transient. Acute infarction ramipril efficacy aire study investigators. This research is designed to study the effect of the ramipril on different survival times of survivors of acute myocardial infarction with heart failure.
The extension to the aire study airex showed that giving ramipril for one year provided continuing mortality benefit for up to 59 months hall et al, 1997. Effects of an angiotensinconvertingenzyme inhibitor, ramipril, on. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with. Ramipril significantly reduces cardiovascular events in highrisk patients with normal ejection fractions classics series.
The heart outcomes prevention evaluation hope study was a landmark study employing the angiotensinconverting enzyme ace inhibitor ramipril. Common side effects include headaches, dizziness, feeling tired, and cough. Effect of ramipril on mortality and morbidity of survivors of acute ncbi. Pertinent research findings in relation to ace inhibitors and myocardial infarction suggest that. Winter, sm bogle, af mackintosh, gd murray, sg ballthe acute infarction ramipril efficacy aire study. Followup was for a minimum of 42 months and a mean of 59 months. Summarysurvival after acute myocardial infarction has been enhanced by treatment with thrombolytic agents, aspirin, and beta adrenoceptor blockade. The prognostic significance of a history of systemic. Ramipril efficacy aire study, 2006 patients with clinical or radiological evidence of heart failure were randomised to ramipril 5mg twice daily or placebo within 29 days of an acute mi. These different survival times, correspond to different defined end points. The heart outcomes prevention evaluation hope study. First, this study makes claims for the enhanced survival of patients on ramipril, but there are no data on morbidity or cause of death in either group. Effects of ramipril on cardiovascular and microvascular.
1022 1400 591 1165 1076 339 825 813 1559 1026 769 1012 812 366 1230 929 519 448 637 131 1405 570 1222 908 372 1597 1283 1544 221 1472 934 1174 270 256 362 215